Harrison Cotler, DO
Surgery · Oakhurst, NJNPI 1679969950
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 93.0% of it on its own, with 40 other manufacturers making up the rest. Reporting peaked in 2024 at $60,155 and has fallen 52.7% since, to $28,445 in 2025. Among surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 386 payments — averaging $387.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$139K
- Intuitive Surgical$4K
- TELA Bio, Inc.$3K
- Davol Inc.$818
- Dilon Technologies, Inc.$479
- Stryker$165
- plus $2K from 35 others
What the payments were for
- Consulting fees$77,50652%
- Speaking & faculty fees$3,2182%
- Travel & lodging$52,43635%
- Food & beverage$13,2859%
- Education$3,0002%
- Gifts$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 266 | $138,929 |
| Intuitive Surgical | 13 | $3,582 |
| TELA Bio, Inc. | 21 | $3,335 |
| Davol Inc. | 7 | $818 |
| Dilon Technologies, Inc. | 3 | $479 |
| Stryker | 1 | $165 |
| Johnson & Johnson(2 entities) | 6 | $150 |
| Amgen | 2 | $150 |
| Baxter Healthcare | 1 | $146 |
| Smith+Nephew | 7 | $141 |
| AstraZeneca | 2 | $133 |
| Boston Scientific | 2 | $127 |
| Baudax Bio Inc. | 1 | $125 |
| Sanofi | 1 | $125 |
| Innovation Technologies Inc | 1 | $107 |
| Kerecis Limited | 3 | $92 |
| Vertex | 5 | $85 |
| Kowa Pharmaceuticals America, Inc. | 5 | $70 |
| Sanara Medtech Inc. | 2 | $63 |
| Innocoll Pharmaceuticals Limited | 3 | $62 |
| Biotissue Holdings Inc. | 2 | $60 |
| Acera Surgical, Inc. | 2 | $55 |
| Avita Medical Americas, LLC | 3 | $51 |
| Conmed Corporation | 1 | $44 |
| Merck | 2 | $42 |
| Eisai Inc. | 2 | $38 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $37 |
| Lifenet Health | 1 | $32 |
| Reprise Biomedical, Inc. | 2 | $30 |
| Solventum Corporation | 1 | $19 |
| Medtronic | 1 | $18 |
| AbbVie | 1 | $15 |
| Convatec Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
| Acell, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Abbott | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Misonix Inc | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$234,601
- INTEGRA DERMAL REGENERATION TEMPLATE$17,859
- PRIMATRIX$17,712
- CYTAL$15,434
- ADVANCED WOUND CARE$15,405
- NEURAGEN$10,126
- Da Vinci Surgical System$3,328
- GENTRIX$2,884
- OviTex 2S$2,123
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$752
- OMNIGRAFT$592
- HemoBlast Bellows$479
- SURGIMEND$429
- PHASIX$337
- 1688$165
- ARISTA AH FLEXITIP$147
- ANJESO$125
- DUPIXENT$125
- FARXIGA$119
- Irrisept$107
How this compares
$149,450 in reported general payments places this provider in the 95th percentile of 593 surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $87,703 |
| Methocarbamol | 51 | $145 |
| Tramadol Hcl | 85 | $71 |
| Oxycodone Hcl | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $141 | $87,70313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 593 surgery providers in New Jersey.
Other surgery in Oakhurst
- Robert PerezHainesport$2M
- Eric WhitmanMorristown$848K
- Jarrod KaufmanBrick$474K
- Amit TrivediParamus$242K
- Young HongCamden$203K
- Harvey RainvilleGlen Ridge$159K
- Francis PrevitiNorth Field$131K
- David DupreeTinton Falls$124K
- Patricia MartzCape May Court House$98K
- Rory SneparShrewsbury$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.